SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy, ...

Actuate Therapeutics' elraglusib shows promise for pancreatic cancer, but financial instability and risks make it a high-risk ...

Hundreds of cubes of human brain tissue help scientists to chart the energy-making capabilities of various brain regions.

Cancer advocates, researchers, clinicians and patients are speaking out in a new STAT News article published this week about ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive safe ...

Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive ...

The heads of U.S. and Russian spy agencies have spoken by phone and agreed to keep up regular contacts to lower the temperature in U.S.-Russia relations ... and the head of SVR, Russia's foreign ...

It uncovered something worrisome. “I had a mass on my pancreas,” he says. “The doctor there was not ready to tell me I had pancreatic cancer.” The following day, he underwent an MRI ...

The most common pathology affecting the pancreas is excess intra-pancreatic fat deposition (IPFD), often called fatty pancreas disease (FPD) — a disorder experienced by roughly one fifth of the ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Stella Osoba is the Senior Editor ...